PinPoint

Einzelheiten

Land

Großbritannien

Typologie

Eigenkapital

Endtermin

20/03/2025 (31 Tage)

Investoren

1104

“The PinPoint Test is an AI-driven cancer diagnostic software developed with the support of NHS England. It’s designed to address the twin challenges of early detection & capacity management for healthcare systems globally, accelerating routes to diagnosis & treatment for those at greatest risk.”